Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy in the elderly patient].

A Romiti1, B Spigone, A Oliveti

  • 1Istituto Nazionale per la Ricerca sul Cancro, Sezione di Roma, Dipartimento di Medicina Sperimentale e Patologia, Università, Roma.

Recenti Progressi in Medicina
|September 13, 2001
PubMed
Summary

Elderly cancer patients can now receive full-dose chemotherapy if healthy, a shift from past exclusion. Future strategies require personalized treatments and optimized schedules for this growing population.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

Ethical issues in perinatal communication.

European journal of pediatrics·2024
Same author

Single-center, prospective, and observational study on the management and treatment of impetigo in a pediatric population.

European review for medical and pharmacological sciences·2023
Same author

Using IOTA terminology to evaluate fetal ovarian cysts: analysis of 51 cysts over 10-year period.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
Same author

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario': [ESMO Open Volume 7, Issue 2, April 2022, 100406].

ESMO open·2022

Area of Science:

  • Geriatric Oncology
  • Clinical Pharmacology
  • Cancer Treatment

Context:

  • Historically, elderly cancer patients were often excluded from chemotherapy due to concerns about disease progression and treatment toxicity.
  • This approach has evolved, with current evidence supporting full-dose chemotherapy for older adults (70-80 years) who have good performance status and no severe comorbidities.

Purpose:

  • To review the changing clinical approach to cancer treatment in elderly patients.
  • To highlight the need for optimized and individualized chemotherapy strategies for the growing population of older adults with cancer.

Summary:

  • Clinical data now indicate that elderly patients, previously excluded from chemotherapy and clinical trials, can tolerate full-dose treatment under specific conditions.
  • The increasing prevalence of cancer in older adults necessitates personalized treatment plans and enhanced clinical surveillance.

Related Experiment Videos

Impact:

  • This shift allows more elderly cancer patients to access potentially life-extending treatments.
  • Future research should focus on identifying optimal chemotherapy schedules tailored to the unique needs of geriatric cancer patients.